- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
MetaVia Inc (MTVA)
Assess today's live MetaVia Inc (MTVA) share price, performance and insights using our live NASDAQ: MTVA stock exchange data.
Analyse the historical data and MetaVia Inc share price performance charts on this page. Our technical summary section provides analysis on MetaVia share price buy/sell indicators using real-time data (or discuss the MetaVia (MTVA) stock price today with other investors in the MetaVia NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ MTVA share price (ISIN: US64132R4048) to enhance your trading decisions with our free investment tools and resources.
What Is the MetaVia Inc Share Price Today?
The MetaVia share price today is 0.6845.
What Is the Stock Symbol for MetaVia Inc
The stock symbol (or 'ticker') for MetaVia Inc is "MTVA."
What Stock Exchange Does MetaVia Inc Trade On?
MetaVia Inc is listed and trades on the NASDAQ stock exchange.
Is MetaVia Inc a Good Stock to Buy?
Determining whether MetaVia Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and MetaVia Inc share price performance charts on this page. Our technical summary section provides analysis on MetaVia share price buy/sell indicators using real-time data (or discuss the MetaVia (MTVA) stock price today with other investors in the MetaVia NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ MTVA share price (ISIN: US64132R4048) to enhance your trading decisions with our free investment tools and resources.
What Is the MetaVia Inc Share Price Today?
The MetaVia share price today is 0.6845.
What Is the Stock Symbol for MetaVia Inc
The stock symbol (or 'ticker') for MetaVia Inc is "MTVA."
What Stock Exchange Does MetaVia Inc Trade On?
MetaVia Inc is listed and trades on the NASDAQ stock exchange.
Is MetaVia Inc a Good Stock to Buy?
Determining whether MetaVia Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
0.6845
+0.0087(+1.29%)
Closed·
After Hours
0.6899+0.0054(+0.7889%)
·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.6554
0.6983
52 wk Range
0.6470
5.3000
MTVA Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
MTVA is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.65540.6983
52 wk Range
0.64705.3000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
MTVA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
15.5000
Upside
+2,164.43%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- MetaVia secures $10 million in private placement
- Investing.com
- MetaVia reports promising obesity drug trial results
- Investing.com
- MetaVia secures $10 million in private placement
- Investing.com
MetaVia Company Profile
MetaVia Inc., a clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases. It develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy that is in Phase 2a clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, as well as completed Phase 1 clinical trial for the treatment of type 2 diabetes mellitus; and DA-1726, a novel oxyntomodulin analogue functioning as a GLP-1 receptor and glucagon receptor dual agonist, which is in Phase 1 trial for the treatment of obesity. The company’s therapeutic programs include ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 for the treatment of cognitive impairment; and Gemcabene for the treatment of dyslipidemia. It has a license agreement with Pfizer Inc. for the research, development, manufacture, and commercialization of Gemcabene; and Dong-A ST, a sole manufacturer for the production of DA-1241 and DA-1726. The company was formerly known as NeuroBo Pharmaceuticals, Inc. and changed its name to MetaVia Inc. in November 2024. MetaVia Inc. is headquartered in Cambridge, Massachusetts.
Compare MTVA to Peers and Sector
Metrics to compare | MTVA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMTVAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.2x | −3.4x | −0.5x | |
PEG Ratio | −0.01 | 0.00 | 0.00 | |
Price/Book | 1.4x | 1.8x | 2.6x | |
Price / LTM Sales | - | 25.6x | 2.9x | |
Upside (Analyst Target) | - | 200.3% | 49.4% | |
Fair Value Upside | Unlock | −2.8% | 8.2% | Unlock |
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 15.5000
(+2,164.43% Upside)
Earnings
Latest Release
Mar 20, 2025
EPS / Forecast
-0.51 / -0.98
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the MetaVia (MTVA) Stock Price Today?
The MetaVia stock price today is 0.68
What Stock Exchange Does MetaVia Trade On?
MetaVia is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for MetaVia?
The stock symbol for MetaVia is "MTVA."
What Is the MetaVia Market Cap?
As of today, MetaVia market cap is 5.92M.
What Is MetaVia's Earnings Per Share (TTM)?
The MetaVia EPS (TTM) is -2.71.
From a Technical Analysis Perspective, Is MTVA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.